Jim Simons Moderna, Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Moderna, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,010,758 shares of MRNA stock, worth $31.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,010,758

Previous 310,300 225.74%

Holding current value

$31.3 Million

Previous $20.7 Million 102.67%

% of portfolio

0.07%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$36.85 - $63.93 $25.8 Million - $44.8 Million	700,458 Added 225.74%	1,010,758 $42 Million
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $14.3 Million - $28.1 Million	224,400 Added 261.23%	310,300 $20.7 Million
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $2.22 Million - $3.65 Million	-21,900 Reduced 20.32%	85,900 $10.2 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $9.2 Million - $12.4 Million	107,800 New	107,800 $11.5 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $16.6 Million - $22.5 Million	-140,013 Reduced 41.58%	196,699 $23.9 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $38.6 Million - $56.1 Million	284,748 Added 547.97%	336,712 $51.7 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $108 Million - $191 Million	-911,077 Reduced 94.6%	51,964 $9.33 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $144 Million - $237 Million	-1,221,100 Reduced 55.91%	963,041 $114 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $191 Million - $289 Million	-1,634,039 Reduced 42.8%	2,184,141 $312 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $251 Million - $466 Million	1,984,458 Added 108.22%	3,818,180 $658 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $37.5 Million - $61.2 Million	-166,021 Reduced 8.3%	1,833,722 $466 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $264 Million - $576 Million	-1,188,711 Reduced 37.28%	1,999,743 $770 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $202 Million - $365 Million	1,552,925 Added 94.95%	3,188,454 $749 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $12.8 Million - $21.8 Million	-117,195 Reduced 6.69%	1,635,529 $214 Million
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $115 Million - $298 Million	1,752,724 New	1,752,724 $183 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $17.1 Million - $29.9 Million	-315,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $9.36 Million - $25.2 Million	315,400 New	315,400 $20.3 Million
Q3 2019 Nov 13, 2019	SELL	$12.26 - $18.07 $3.45 Million - $5.09 Million	-281,800 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.7 - $28.34 $3.86 Million - $7.99 Million	281,800 New	281,800 $4.13 Million

Others Institutions Holding MRNA

# of Institutions

925

Shares Held

256M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account